Related Experiment Videos
Differential effects of antihypertensive agents in experimental and human atherosclerosis
1Division of Cardiovascular Medicine, Stanford University School of Medicine, California.
Insights
Hypertension and atherosclerosis involve complex factors like endothelial dysfunction and metabolic issues. Certain antihypertensive drugs, such as ACE inhibitors, may help manage these conditions and prevent atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertension and atherosclerosis share complex pathophysiological links.
- These include endothelial dysfunction, metabolic abnormalities, and impaired vascular function.
Purpose of the Study:
- To explore the intricate relationship between hypertension and atherosclerosis.
- To identify antihypertensive therapies that favorably impact atherosclerosis progression.
Main Methods:
- Review of experimental and human studies.
- Analysis of disease manifestations and therapeutic responses across diverse populations and conditions.
Main Results:
- Significant heterogeneity exists in disease presentation and treatment response.
- Angiotensin-converting enzyme (ACE) inhibitors, calcium antagonists, and alpha-blockers show promise.
Conclusions:
- Antihypertensive therapy selection is crucial for managing atherosclerosis.
- Targeted agents can positively modulate disease facets, aiming to prevent or regress atherosclerosis.
Abstract:
The association between hypertension and atherosclerosis is complex, incorporating endothelial dysfunction, abnormalities of insulin and lipid metabolism, altered vascular biology, and impaired arterial compliance. Results of experimental and human studies suggest that there is heterogeneity in the manifestations of disease and responses to therapy among different animal species, vascular territories, and individual patients. Antihypertensive therapy requires the careful selection of specific agents that reduce blood pressure and preferentially and positively modulate the synergistic interaction of the many facets of disease, with the goal of preventing or regressing atherosclerosis. Angiotensin-converting enzyme (ACE) inhibitors, calcium antagonists, and alpha-blockers appear to hold the greatest promise in this regard.